IRADIMED CORPORATION (NASDAQ:IRMD) Q4 2024 Earnings Conference Call February 13, 2025 11:00 AM ET
Company Participants
Roger Susi – Founder, President and CEO
John Glenn – Chief Financial Officer
Conference Call Participants
Jason Wittes – ROTH Capital Partners
Nelson Cox – Lake Street Capital Markets
Operator
Welcome to the IRADIMED CORPORATION Fourth Quarter of 2024 Financial Results Conference Call. Currently, all participants are in a listen-only mode. And at the end of the call, we will conduct the question-and-answer session. This call is being recorded today, February 13, 2025 and contains time-sensitive accurate information only today.
Earlier, IRADIMED released its financial results for the fourth quarter of 2024. A copy of this press release announcing the company’s earnings is available under the heading news on their website at iradimed.com.
A copy of the press release was also furnished to the Securities and Exchange Commission on Form 8-K and can be found at sec.gov. This call is being broadcast live over the Internet on the company’s website at iradimed.com, and a replay will be available on the website for the next 90 days. Some of the information in today’s session will constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements focus on future performance, results, plans and events that may include the company’s expected future results. IRADIMED reminds you that future results may differ materially from these forward-looking statements due to several risk factors. For a description of the relevant risks and uncertainties that may affect the company’s business, please see the Risk Factors section of the company’s most recent reports filed with the Securities and Exchange Commission which may be obtained free from the SEC’s website at sec.gov.
I would now like to turn the call over to Roger Susi, President and Chief
Read the full article here
